Europe Pharmacokinetics Services Market Size & Outlook

The pharmacokinetics services market in Europe is expected to reach a projected revenue of US$ 483.8 million by 2030. A compound annual growth rate of 6.8% is expected of Europe pharmacokinetics services market from 2024 to 2030.
Revenue, 2023 (US$M)
$305.5
Forecast, 2030 (US$M)
$483.8
CAGR, 2024 - 2030
6.8%
Report Coverage
Europe

Europe pharmacokinetics services market, 2018-2030 (US$M)

Europe

Europe pharmacokinetics services market highlights

  • The Europe pharmacokinetics services market generated a revenue of USD 305.5 million in 2023.
  • The market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
  • In terms of segment, small molecules was the largest revenue generating type in 2023.
  • Small Molecules is the most lucrative type segment registering the fastest growth during the forecast period.


Europe data book summary

Market revenue in 2023USD 305.5 million
Market revenue in 2030USD 483.8 million
Growth rate6.8% (CAGR from 2023 to 2030)
Largest segmentSmall molecules
Fastest growing segmentSmall Molecules
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSmall Molecules
Key market players worldwideEvotec SE, Certara Inc Ordinary Shares, Pacific Biosciences of California Inc, Pharmaceutical Product Development, Charles River Laboratories International Inc, PAREXEL, Eurofins Scientific SE, SGS AG, LGC Group, Leica Biosystems, GVK Biosciences, Shanghai Medicilon, Frontage Laboratories, Creative Bioarray


Other key industry trends

  • In terms of revenue, Europe region accounted for 28.8% of the global pharmacokinetics services market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 499.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmacokinetics Services Market Scope

Pharmacokinetics services market segmentation & scope
Small Molecules
Large Molecules (Biopharmaceuticals)
Application
Small and Medium Enterprise
Large Enterprise
End User
Biotechnology & Pharmaceutical Companies
Academic and Government Research Institutes
Others

Pharmacokinetics Services Market Companies

Name Profile # Employees HQ Website

Europe pharmacokinetics services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmacokinetics services market will help companies and investors design strategic landscapes.


Small molecules was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe pharmacokinetics services market based on small molecules covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe pharmacokinetics services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe pharmacokinetics services market databook

  • Our clientele includes a mix of pharmacokinetics services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe pharmacokinetics services market , including forecasts for subscribers. This continent databook contains high-level insights into Europe pharmacokinetics services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe pharmacokinetics services market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more